Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling

Blood (2018) 132 (Supplement 1): 3072.

https://doi.org/10.1182/blood-2018-99-119221

Published: 2018

Journal Articles

Comparison of the Functional Characteristics and Post-Translational Modifications of Commercial Factor VIII Products

Guido Kohla, PhD, Larisa Belyanskaya, PhD, Maya Tiemeyer, PhD, Thole Züchner, PhD, Irena Knappik, PhD, Julia Rosenlöcher, PhD

Blood (2017) 130 (Supplement 1): 2362.

https://doi.org/10.1182/blood.V130.Suppl_1.2362.2362

Published: 2017

Journal Articles

A Factor VIII Fusion with an Inactivated FIX Generates a Biologically Active Molecule with Delayed Clearance in a FVIII/VWF Knockout Mouse Model

Oladipo Jude Akinwale, MSc,BSc, Ian Wilkinson, PhD, Christine Hough, PhD, David Lillicrap, MD FRCPC, Michael Makris, MD, Richard Ross, MD FRCP

Blood (2017) 130 (Supplement 1): 2344.

https://doi.org/10.1182/blood.V130.Suppl_1.2344.2344

Published: 2017

Journal Articles

Effects of the Sympathicomimetic Agonist Mirabegron on Disease Course, Mutant Allele Burden, Marrow Fibrosis, and Nestin Positive Stem Cell Niche in Patients with JAK2 -Mutated Myeloproliferative Neoplasms. a Prospective Multicenter Phase II Trial SAKK 33/14

Beatrice Drexler, MD, Jakob Passweg, MD, Martin Bigler, Alexandre PA Theocharides, MD, Nathan Cantoni, MD, Peter Keller, MD, Georg Stuessi, MD, Axel Rüfer, MD, Rudolf A. Benz, MD, Geneviève Favre, MD, Alexandar Tzankov, MD, Pontus Lundberg, PhD, Andrea Fuhrer, PhD, Christine Biaggi, Markus G Manz, MD, Mario Bargetzi, MD, Simon Mendez-Ferrer, PhD, Radek C. Skoda, MD

Blood (2016) 128 (22): 3108.

https://doi.org/10.1182/blood.V128.22.3108.3108

Published: 2016

Journal Articles

Bone Marrow-Specific Loss of ABI1 Induces Myelofibrosis through a Mechanism Involving Activation of NFκB

Blood (2016) 128 (22): 1203.

https://doi.org/10.1182/blood.V128.22.1203.1203

Published: 2016

Journal Articles

Interleukin-13- and Tansforming Growth Factor- β - Producing Mast Cells Are Associated with Fibrosis in Bone Marrow

Shoko Nakayama, Taiji Yokote, Nobuya Hiraoka, Toshikazu Akioka, Takuji Miyoshi, Kazuki Iwaki, Ayami Fumimoto, Uta Nishiwaki, Yuki Masuda, Jun Hatooka, Mayumi Fujimoto, Motomu Tsuji

Blood (2016) 128 (22): 3112.

https://doi.org/10.1182/blood.V128.22.3112.3112

Published: 2016

Journal Articles

Ptdglc-Enriched Lipid Rafts Are a Novel Platform for Apoptosis Signaling in Human Neutrophilic Lineage Cells

Roudy Chiminch Ekyalongo, Noriko Yokoyama, Hitoshi Nakayama, Hideoki Ogawa, Yoko Tabe, Kenji Takamori, Yoshio Hirabayashi, Kazuhisa Iwabuchi

Blood (2015) 126 (23): 4968.

https://doi.org/10.1182/blood.V126.23.4968.4968

Published: 2015

Journal Articles

Final Results from a Phase 4 Open-Label 3-Year Study Evaluating Changes in Bone Marrow (Bm) Morphology in Adult Immune Thrombocytopenia (ITP) Patients (Pts) Receiving the Thrombopoietin Mimetic Romiplostim

Ann Janssens, Francesco Rodeghiero, David Anderson, Beng Chong, Zoltan Boda, Ingrid Pabinger, Libor Cervinek, MD PhD, Xuena Wang, Angela Lopez

Blood (2014) 124 (21): 2774.

https://doi.org/10.1182/blood.V124.21.2774.2774

Published: 2014

Journal Articles

Masked Polycythemia Vera (mPV): Results Of An International Study

Tiziano Barbui, MD, Jürgen Thiele, MD, PhD, Heinz Gisslinger, MD, Guido Finazzi, Alessandra Carobbio, MSc, Elisa Rumi, MD, Maria Luigia Randi, MD, Alessandro M. Vannucchi, MD, Lisa Pieri, MD, PhD, Bettina Gisslinger, Leonhard Muellauer, M.D., Marco Ruggeri, MD, Alessandro Rambaldi, MD, Ayalew Tefferi, MD

Blood (2013) 122 (21): 1581.

https://doi.org/10.1182/blood.V122.21.1581.1581

Published: 2013

Journal Articles

Results From a Phase IV Open-Label Study Evaluating Changes In Bone Marrow Morphology In Adult Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim: Analysis Of The 1- and 2-Year Romiplostim Cohorts

Ann Janssens, MD, Francesco Rodeghiero, David Anderson, Beng Chong, MBBS FRCPA FRACP PhD, Zoltan Boda, Ingrid Pabinger, Libor Cervinek, Xuena Wang, Angela Lopez

Blood (2013) 122 (21): 2312.

https://doi.org/10.1182/blood.V122.21.2312.2312

Published: 2013

Journal Articles

Bone Marrow-Derived Mensenchymal Stem Cells Modified by Mouse Interferon-γ Gene Reduce Fibrosis and Improve Function In a Mouse Model of Liver Fibrosis.

Hongli Xue, Shijia Ling, Dong He, Yanjun Wen, Wentong Meng, Ting Niu, MD, PhD

Blood (2010) 116 (21): 3768.

https://doi.org/10.1182/blood.V116.21.3768.3768

Published: 2010

Journal Articles

Evidence for Reduced Angiogenesis in Bone Marrow of Systemic Sclerosis Patients Immunohistochemetry and Computerized Imagine Analysis.

Valentina Carrai, Renato Alterini, Riccardo Saccardi, Irene Miniati, Luigi Rigacci, Gloria Capaccioli, Irene Donnini, Giada Rotunno, Alberto Bosi, Marco Matucci Cerinic

Blood (2009) 114 (22): 5126.

https://doi.org/10.1182/blood.V114.22.5126.5126

Published: 2009

Journal Articles

Purification of Anti-HPA-1a Directly from Plasma Using Immobilised Recombinant HPA-1a Enables Determination of Antibody Affinity by Surface Plasmon Resonance Technology in Neonatal Alloimmune Thrombocytopenia.

Hagop Bessos, BSc, MSc, PhD, FRCPath, Pamela Brown, BSc, PhD, Gholamreza Anani Sarab, MSc, Shirley Gibson, MIBMS, Michael Moss, BSc, PhD, Robert N Barker, BSc, PhD, Stanislaw J Urbaniak, MBChB, PhD, FRCP, FRCPath

Blood (2008) 112 (11): 3402.

https://doi.org/10.1182/blood.V112.11.3402.3402

Published: 2008

Journal Articles

Successful Reduced-Intensity Conditioning (RIC) Allogeneic Transplantation of Peripheral Blood Stem Cells and Bone Marrow Cells in an Advanced Idiopathic Myelofibrosis with Myeloid Myeloaplasia (MMM).

Zhisheng Jiang, MD, Da Li, MD, Shunjie Wu, MD, Ying Kang, MD, Kun Liu, MD, Xinghao Lan, MD, Wei Yi, MD, Ailing Peng, MD, Yanling Ou, MD, Linling Jiang, MD

Blood (2007) 110 (11): 5057.

https://doi.org/10.1182/blood.V110.11.5057.5057

Published: 2007

Journal Articles

Recombinant Chimeric IgA1 and IgA2 Antibodies for Tumor Immunotherapy.

Michael Dechant, MD, Thomas Beyer, PhD, Stefan Lohse, Tanja Schneider-Merck, PhD, Wencke Weisner, Sven Berger, PhD, Matthias Peipp, PhD, Jan G.J. van de Winkel, PhD, Thomas Valerius, MD

Blood (2007) 110 (11): 4892.

https://doi.org/10.1182/blood.V110.11.4892.4892

Published: 2007

Journal Articles

Evaluation of Microsatellite Instability and Loss of Heterozygosity in Defining the Instability Phenotype of Myelodysplastic Syndromes.

Maria Lorena Vazquez, MS, Jorge Arbelbide, MD, Dorotea Beatriz Fantl, MD, Elsa Nucifora, MD, Irene Larripa, PhD, Ariela Fundia, PhD

Blood (2007) 110 (11): 4620.

https://doi.org/10.1182/blood.V110.11.4620.4620

Published: 2007

Journal Articles

Quantitative Assessment of Hematopoietic Chimerism after Allogeneic Nonmyeloablative Stem Cell Transplantation.

Bao-An Chen, MD, PhD, Hui-Xia Xiong, MD, Jia-Hua Ding, MD, Chong Gao, MD, Yun-Yu Sun, MD, Jun Wang, MD, Jian Cheng, MD, Gang Zhao, MD, Ning-Na Chen, MD, Fei Fei, MD

Blood (2006) 108 (11): 5234.

https://doi.org/10.1182/blood.V108.11.5234.5234

Published: 2006

Journal Articles

Bone Marrow Reticulin in Patients with Immune Thrombocytopenic Purpura.

Ghulam Mufti, Adam Bagg, Robert Hasserjian, Barbara Bain, David Kuter, Lyndah Dreiling, Janet Nichol

Blood (2006) 108 (11): 3982.

https://doi.org/10.1182/blood.V108.11.3982.3982

Published: 2006

Journal Articles

Bone Marrow Fibrosis Is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma.

Shankaranarayana Paneesha, MD, MRCP, MRCPath, Raj Pol, N. Chachlani, Guy Pratt, Peter Rose, Anton Borg

Blood (2006) 108 (11): 5059.

https://doi.org/10.1182/blood.V108.11.5059.5059

Published: 2006

Journal Articles

Bone Marrow Fibrosis Is a Not Predictor of Overall Survival in Patients with Myeloma.

P. Roberts, S. Paneesha, H. Freeman, G. Pratt, N. Chachalani, P. Rose, Anton Borg

Blood (2005) 106 (11): 5091.

https://doi.org/10.1182/blood.V106.11.5091.5091

Published: 2005

NARROW

rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling

Comparison of the Functional Characteristics and Post-Translational Modifications of Commercial Factor VIII Products

A Factor VIII Fusion with an Inactivated FIX Generates a Biologically Active Molecule with Delayed Clearance in a FVIII/VWF Knockout Mouse Model

Effects of the Sympathicomimetic Agonist Mirabegron on Disease Course, Mutant Allele Burden, Marrow Fibrosis, and Nestin Positive Stem Cell Niche in Patients with JAK2 -Mutated Myeloproliferative Neoplasms. a Prospective Multicenter Phase II Trial SAKK 33/14

Bone Marrow-Specific Loss of ABI1 Induces Myelofibrosis through a Mechanism Involving Activation of NFκB

Interleukin-13- and Tansforming Growth Factor- β - Producing Mast Cells Are Associated with Fibrosis in Bone Marrow

Ptdglc-Enriched Lipid Rafts Are a Novel Platform for Apoptosis Signaling in Human Neutrophilic Lineage Cells

Final Results from a Phase 4 Open-Label 3-Year Study Evaluating Changes in Bone Marrow (Bm) Morphology in Adult Immune Thrombocytopenia (ITP) Patients (Pts) Receiving the Thrombopoietin Mimetic Romiplostim

Masked Polycythemia Vera (mPV): Results Of An International Study

Results From a Phase IV Open-Label Study Evaluating Changes In Bone Marrow Morphology In Adult Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim: Analysis Of The 1- and 2-Year Romiplostim Cohorts

Bone Marrow-Derived Mensenchymal Stem Cells Modified by Mouse Interferon-γ Gene Reduce Fibrosis and Improve Function In a Mouse Model of Liver Fibrosis.

Evidence for Reduced Angiogenesis in Bone Marrow of Systemic Sclerosis Patients Immunohistochemetry and Computerized Imagine Analysis.

Purification of Anti-HPA-1a Directly from Plasma Using Immobilised Recombinant HPA-1a Enables Determination of Antibody Affinity by Surface Plasmon Resonance Technology in Neonatal Alloimmune Thrombocytopenia.

Successful Reduced-Intensity Conditioning (RIC) Allogeneic Transplantation of Peripheral Blood Stem Cells and Bone Marrow Cells in an Advanced Idiopathic Myelofibrosis with Myeloid Myeloaplasia (MMM).

Recombinant Chimeric IgA1 and IgA2 Antibodies for Tumor Immunotherapy.

Evaluation of Microsatellite Instability and Loss of Heterozygosity in Defining the Instability Phenotype of Myelodysplastic Syndromes.

Quantitative Assessment of Hematopoietic Chimerism after Allogeneic Nonmyeloablative Stem Cell Transplantation.

Bone Marrow Reticulin in Patients with Immune Thrombocytopenic Purpura.

Bone Marrow Fibrosis Is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma.

Bone Marrow Fibrosis Is a Not Predictor of Overall Survival in Patients with Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only